Late clinical events after drug-eluting stents: is there a problem?

Recent presentations at the joint meeting of the European Society of Cardiology and World Congress of Cardiology in Barcelona, Spain, highlighted the potential problem of very late stent thrombosis and increased non-cardiac death occurring in drug-eluting stents (DES) (see pages 317–18). The presentations received major publicity, not least because of the comments of the designated discussant Professor Salim Yusuf (McMaster University, Hamilton, Canada) at one of the conference Hot Line sessions.